News & Insights

All articles

Every article published by PCL Research & Manufacturing: polymorph screening, solid-form selection, HPAPI containment, controlled substances, GMP analysis and company news.

13 articles

Insights

Designing a Co-Crystal Screening Program: A Practical Checklist

A practical, step-by-step framework for teams who need defensible solid-form data, not just a longer polymorph report.

13 Nov 20264 min read
Insights

Characterizing Amorphous Solid Dispersions: Why XRPD Alone Isn't Enough

A single diffractogram cannot confirm miscibility, physical stability, or manufacturability.

10 Nov 20265 min read
Insights

Same Molecule, Same Rights? The Rifaximin Lesson in Solid-State Strategy

Rifaximin's polymorph dispute shows that chemical identity alone does not guarantee commercial or regulatory equivalence.

1 Nov 20266 min read
Insights

When the Wrong Crystal Form Becomes a Regulatory Problem, Not Just a Lab One

Regulators, patent examiners, and investors now expect sponsors to understand and control crystal form, not just report it after the fact.

30 Oct 20266 min read
Insights

From 10 Grams to 10 Kilograms: Mapping Solid Form Stability in HPAPI Scale-Up

An anonymized project shows why polymorph behavior validated at gram scale cannot be assumed to hold at kilogram scale.

23 Oct 20267 min read
Insights

Solid-State Analytics: The Subcontracted Blind Spot in CDMO Sourcing

When generalist CDMOs quietly outsource polymorph and crystal form work, you lose visibility, speed, and accountability.

21 Oct 20267 min read
Insights

The Three Failure Points in Quantitative XRPD Method Validation

A technical review of the specificity, linearity, and detection-limit gaps that most often trigger regulatory observations in quantitative XRPD methods.

19 Oct 20267 min read
Insights

Four Questions to Ask Before Locking In an API's Crystal Form

A plain-language framework for project managers and procurement leaders deciding when a solid form is truly ready to lock.

18 Oct 20265 min read
Insights

Sequencing Analytical Development for Scheduled Compounds, Step by Step

A practical, step-by-step approach to building controlled substance analytical programs that survive the transition from discovery to GMP release.

16 Oct 20267 min read
Insights

Why First-Time-Right Should Replace Fastest-to-File as the Default CMC Mindset

A closer look at why rushing CMC data packages often costs more time than it saves — and what to do instead.

14 Oct 20265 min read
Insights

A Phase-Appropriate Roadmap for Validating Solid-State Analytical Methods

A practical, stage-by-stage checklist for validating XRPD, DSC/TGA, SS-NMR and Raman methods without over-investing early or scrambling late.

7 Oct 20265 min read
Insights

Solid-State Method Development for a High-Potency Intermediate Under OEB5

An anonymized case study on reconciling high-containment safety, analytical sensitivity, and audit-ready data for a cytotoxic intermediate.

6 Oct 20266 min read
Insights

Disappearing Polymorphs Are a Business Risk, Not Just a Lab Curiosity

A plain-language guide for program managers and procurement leaders on the business risk behind vanishing crystal forms.

1 Oct 20267 min read